Current Edition

CPhI partners with SGS for Company Verification Service

The ‘CPhI Verified’ certificate will provide pharma companies with an internationally accredited pre-qualification service

CPhI announces the launch of CPhI Verified for selected companies listed on CPhI Online. CPhI Online is the largest pharma marketplace and content hub. CPhI Verified is developed  in partnership with SGS – the world’s leading verification, inspection and certification company. CPhI Verified will enable companies to prove customer and stakeholder requirements, build trust and brand loyalty – providing a benchmark of legal, regulatory, quality and company pre-qualification compliance.

CPhI Verified companies will have an overview of potential opportunities for improvement.

CPhI Verified is included as part of the Platinum subscription on CPhI Online. The service will see SGS undertake a detailed review of company information, insurance, quality management certifications and health and safety standards through to Cooperate Social Responsibility and broader engagement systems.

“We launched the service to further increase trust and transparency among the suppliers on CPhI Online, which is the largest pharma marketplace and content hub in the world. By partnering with SGS, buyers can be assured that potential partners have been pre-qualified for a range of criteria. We knew this was incredibly important to our audiences as global pharma increasing diversifies its supply chain partners, and of course, it also empowers suppliers an important mark to stand apart from global competitors,” commented, Adam Andersen, Group Brand Director at CPhI.

CPhI Online launched the service in response to customer requests for an easily recognisable global benchmark for quality and integrity, and SGS was chosen as the verification partner thanks to being the leading verification, inspection, and certification company

Andersen, added “as supply chains become more global and companies search for new partners. We identified CPhI Verified as a process that could immediately help our audiences, especially as many pharma companies are now looking for increased resilience and alternate partner contingencies.”